Cellectar to participate at upcoming banking conferences

Florham park, n.j., march 08, 2023 (globe newswire) -- cellectar biosciences, inc. (nasdaq: clrb), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced the company will participate in and be available for 1x1 meetings at the following upcoming conferences:

CLRB Ratings Summary

CLRB Quant Ranking